Healthy Living Europe: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.

Press releases published on September 18, 2026

Sep. 18, 2026

Scientists Discover New Biomarkers To Help Monitor Response to Stem Cell Treatment in Multiple Sclerosis

Indeterminate EIN Presswire

Sep. 18, 2026

PitPat Launches Road to Berlin 2KM Virtual Race, Connecting Runners Worldwide Through Digital Competition

Indeterminate EIN Presswire

Sep. 18, 2026

Behavioral Health Market to reach USD 293.5 Billion by 2035 at 4.38% CAGR

Indeterminate EIN Presswire

Sep. 18, 2026

Renal Dialysis Market to reach USD 41.38 Billion by 2035 at 5.6% CAGR

Indeterminate EIN Presswire

Sep. 18, 2026

Healthcare Analytics Market to reach USD 354.90 Billion by 2035 at 20.9% CAGR

Indeterminate EIN Presswire

Sep. 18, 2026

Healthcare Revenue Cycle Management Market to reach USD 140.31 Billion by 2035 at 9.50% CAGR

Indeterminate EIN Presswire

Sep. 18, 2026

Health and Wellness Product Market to reach USD 1,975.77 Billion by 2035 at 9.69% CAGR

Indeterminate EIN Presswire

Sep. 18, 2026

Preclinical CRO Market to reach USD 15.09 Billion by 2035 at 8.0% CAGR

Indeterminate EIN Presswire

Sep. 18, 2026

Medical Oxygen Concentrators Market to reach USD 7.0 Billion by 2035 at 6.26% CAGR

Indeterminate EIN Presswire

Sep. 18, 2026

Chronic Obstructive Pulmonary Disease (COPD) Market to reach USD 72.55 Billion by 2035 at 8.50% CAGR

Indeterminate EIN Presswire

Sep. 18, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Johns Hopkins USFHP is One of the Highest-Rated Health Plans in the Nation

Indeterminate GlobeNewswire

Sep. 18, 2026

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

Indeterminate GlobeNewswire

Sep. 18, 2026

NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

Indeterminate GlobeNewswire

Sep. 18, 2026

Top Antistatic Bag Manufacturer Expands Advanced Protective Packaging Solutions

Indeterminate EIN Presswire

Sep. 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Peptide Review Hub Opens Vendor Registration for Research Suppliers

Indeterminate EIN Presswire

Sep. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire